19 results
Thumbnail

D1.127 - Distinct roles of Natural killer T Cells and Innate Lymphoid Cells in Type I and II airway Inflammation Induced by Viral Infection

Thumbnail

D2.131 - Classification, early determinants and long-term impact on asthma of the IgG responses to rhinovirus VP1 (RV-VP1): a longitudinal study in two birth cohorts

Thumbnail

D2.342 - Changes of MMP-9 and MMP-12 in response of acute viral infection in virtual model of macrophages

Thumbnail

D3.133 - Association between Asthma and Risk of Respiratory Syncytial Virus-Acute Respiratory Infection in Adults 50 Years or Older Before and After the Covid 19-Pandemic in a Midwest Region of the U.S

Thumbnail

D3.354 - Selective IgE deficiency in children: its role in autoimmunity

Thumbnail

D1.139 - Staphylococcus aureus (carriage and sensitization) - is it a significant factor in allergic rhinitis?

Thumbnail

D1.303 - Preschooler with Toxic Epidermal Necrolysis Associated with Adenovirus Respiratory Infection

Thumbnail

D1.316 - Lessons Learned from the Diagnosis and Management of a female pediatric patient with NCF2 Mutations and Chronic Granulomatous Disease

Thumbnail

D1.317 - A Retrospective Analysis of Dengue-Associated Hemophagocytic Lymphohistiocytosis in a Dengue-Endemic Country

Thumbnail

D1.322 - A Prescription for Lower Immunity: The Hidden Cost of Certain Psychiatric Medications

Thumbnail

D1.325 - Autoantibodies to interferon-gamma: clinical features, treatment outcomes, and in-vitro monitoring of disease

Thumbnail

D2.138 - The Effect of Human Milk Oligosaccharides 2’FL and 3FL on Macrophage polarization

Thumbnail

D1.397 - Eosinophilic Pneumonia Triggered by Toxocara canis in a Patient with Kartagener Syndrome: A Case Report Highlighting Diagnostic Challenges and Interdisciplinary Management

Thumbnail

D1.398 - Retrospective study of the effect of bacterial immunotheraphy on patients with chronic respiratory diseases

Thumbnail

D1.403 - Use of ketotifen as treatment for post viral infection cough in children

Thumbnail

D1.404 - Use of inactivated polybacterial mucosal vaccine (IPMV) as part of the treatment for the reduction of recurrent acute respiratory infections

Thumbnail

D1.405 - Immunological imprinting of IgG response to RV VP1 in children of the MAS and PAPS birth cohorts

Thumbnail

D1.406 - The microbiota of the urogenital canal related to papillomavirus infection

Thumbnail

D1.426 - Cellular immunity profile in patients with urolithiasis in the presence of post-Covid syndrome